SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

LogicBio Therapeutics Q3 EPS $(0.48) Up From $(4.03) YoY

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.48) per share. This is a 88.09 percent increase over losses of $(4.03) per share from the same period last year.

Benzinga · -

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.48) per share. This is a 88.09 percent increase over losses of $(4.03) per share from the same period last year.